Şenol Kobak
Şenol Kobak publishes mostly in Rheumatology, Physiology and Pulmonary and Respiratory Medicine, on topics such as Sarcoidosis and Beryllium Toxicity Research, Spondyloarthritis Studies and Treatments and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis.
- World rank
- #7,448,905 of 7,710,434 ranked researchers
- Rank in Türkiye
- #107,179 of 117,622
- Works
- 170
- Citations
- 1.3k
- Citations per work
- 7.7
What does Şenol Kobak research?
Şenol Kobak's work is mostly in Medicine (53%), Biochemistry, Genetics and Molecular Biology (7%), Immunology and Microbiology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences9053.2%
- Medicine9053.2%
- Everything else5934.7%
- Life Sciences2112.1%
- 1Rheumatology22% of their works
- 2Physiology14% of their works
- 3Pulmonary and Respiratory Medicine11% of their works
- 4Surgery7% of their works
- 5Molecular Biology7% of their works
- 6Immunology5% of their works
Research topics
- Sarcoidosis and Beryllium Toxicity Research
- Spondyloarthritis Studies and Treatments
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Rheumatoid Arthritis Research and Therapies
- Ocular Diseases and Behçet’s Syndrome
- Inflammasome and immune disorders
- Autoimmune and Inflammatory Disorders Research
- Systemic Sclerosis and Related Diseases
Which keywords describe Şenol Kobak's research?
The keywords of their largest research topics: Cardiac, Sarcoidosis, Inflammation, Fibrosis, Autoantibodies, Ankylosing Spondylitis, Spondyloarthritis and Juvenile Idiopathic Arthritis.
- Pulmonary Involvement
- Hemophagocytic Lymphohistiocytosis
- Inflammasome
- Behçet's Disease
- Immunosuppressive Therapy
- Interstitial Lung Disease
- Juvenile Idiopathic Arthritis
- Ankylosing Spondylitis
- Fibrosis
- Sarcoidosis
- Cardiac
- Inflammation
- Autoantibodies
- Spondyloarthritis
- Idiopathic Pulmonary Fibrosis
- Biological Therapy
- Rheumatoid Arthritis
- Uveitis
- NLRP3
- Macrophage Activation Syndrome
- Systemic Sclerosis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Cardiac561 topic
- Sarcoidosis561 topic
- Inflammation472 topics
- Fibrosis432 topics
- Autoantibodies412 topics
- Ankylosing Spondylitis341 topic
- Spondyloarthritis341 topic
- Juvenile Idiopathic Arthritis332 topics
- Idiopathic Pulmonary Fibrosis321 topic
- Interstitial Lung Disease321 topic
- Biological Therapy301 topic
- Immunosuppressive Therapy302 topics
- Rheumatoid Arthritis301 topic
- Behçet's Disease191 topic
- Uveitis191 topic
- Inflammasome171 topic
- NLRP3171 topic
- Hemophagocytic Lymphohistiocytosis141 topic
- Macrophage Activation Syndrome141 topic
- Pulmonary Involvement111 topic
- Systemic Sclerosis111 topic
Where does Şenol Kobak work?
Şenol Kobak's main affiliation in the publication record is Şifa University, Türkiye.
How many publications and citations does Şenol Kobak have?
OpenAlex counts 170 works and 1,311 citations for Şenol Kobak, an h-index of 20, ranking #7,448,905 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Şenol Kobak. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.